Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01955668 · ClinicalTrials.gov registry record · Phase 1
AZD6738 First Time in Patient Multiple Ascending Dose Study
A Phase 1 study, sponsored by AstraZeneca.
- Completed
- Registry status
- Phase 1
- Development phase
- 2
- Enrollment target
NCT01955668: Completed Phase 1 study, sponsored by AstraZeneca.
NCT01955668 is a Phase 1 study that has completed, run by AstraZeneca. The registered enrollment target is 2 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01955668, a Phase 1 study, has completed, sponsored by AstraZeneca.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 2 participants
- Enrollment target
Study Summary
In Part A to investigate the safety and tolerability of AZD6738 when given orally to patients with relapsed/refractory CLL, PLL or B cell lymphoma. In Part B to investigate the safety and tolerability of AZD6738 when given orally to patients with prospectively identified 11q deleted or ATM deficient, relapsed/refractory CLL
Primary Outcome
Safety measures include ECG, physical examination, pulse, blood pressure, body temperature, respiratory rate, weight and laboratory variables
Interventions
- DRUG Administration of AZD6738
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2013-11 |
| Est. Completion | 2013-12 |
| Phase | Phase 1 |
What the finished NCT01955668 record still lists
NCT01955668 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Administration of AZD6738 is the first listed.
NCT01955668 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01955668 about?
NCT01955668 is a clinical study titled "AZD6738 First Time in Patient Multiple Ascending Dose Study". In Part A to investigate the safety and tolerability of AZD6738 when given orally to patients with relapsed/refractory CLL, PLL or B cell lymphoma. In Part B to investigate the safety and tolerability of AZD6738 when given orally to patients with prospectively identified 11q deleted or ATM deficien...
What is the current status of trial NCT01955668?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 2 participants. The study started on 2013-11. Estimated completion is 2013-12.
What interventions are being tested in trial NCT01955668?
The interventions under investigation include: Administration of AZD6738 (DRUG).
Who is sponsoring clinical trial NCT01955668?
This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01955668's enrollment target sits among peer trials
2 2000th of 2000 the lowest of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia